July 7, 2026 · Form 4 insider transaction
Swirsky Douglas J bought 37,500 shares of Cellectar Biosciences, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
This option shall vest in full on July 7, 2027, subject to the reporting person's continued service through the applicable vesting date.